您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (9): 14-20.doi: 10.6040/j.issn.1671-7554.0.2020.090

• • 上一篇    下一篇

303例甲状旁腺切除术围术期观察及术后严重低钙血症危险因素分析

张洪彬1,2,赵寒辉2,王素霞2,周鹏3,贺青卿3,王延群4,丁伟平5,柳刚1   

  1. 1. 山东大学第二医院肾内科, 山东大学肾脏病研究所, 山东 济南 250033;2. 中国人民解放军联勤保障部队第九六〇医院血液净化科, 山东 济南 250031;3. 中国人民解放军联勤保障部队第九六〇医院甲状腺乳腺外科, 山东 济南 250031;4. 中国人民解放军联勤保障部队第九六〇医院检验科, 山东 济南 250031;5. 中国人民解放军联勤保障部队第九六〇医院核医学科, 山东 济南 250031
  • 出版日期:2020-09-10 发布日期:2020-08-30
  • 通讯作者: 柳刚. E-mail:lg69007@163.com
  • 基金资助:
    山东省重点研发计划(2017GSF18113)

Perioperative observation and postoperative risk factors of severe hypocalcemia after parathyroidectomy: a report of 303 cases

ZHANG Hongbin1,2, ZHAO Hanhui2, WANG Suxia2, ZHOU Peng3, HE Qingqing3, WANG Yanqun4, DING Weiping5, LIU Gang1   

  1. 1. Department of Nephrology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Nephrology Research Institute of Shandong University, Jinan 250033, Shandong, China;
    2. Department of Blood Purification, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    3. Department of Thyroid and Breast, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    4. Department of Laboratory, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    5. Department of Nuclear Medicine, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China
  • Online:2020-09-10 Published:2020-08-30

PDF (PC)

217

摘要： 目的 探讨甲状旁腺切除术(PTX)治疗难治性继发性甲状旁腺功能亢进(SHPT)围手术期安全性、有效性及发生术后严重低钙血症危险因素。 方法 选取2010年11月至2018年12月在中国人民解放军第九六〇医院行PTX的难治性SHPT患者303例。收集患者术前、术后血全段甲状旁腺素(iPTH),血清钙、磷、碱性磷酸酶等指标,进行统计学分析,观察术后并发症及预后。对严重低钙血症患者行单因素、多因素分析,确定术后发生严重低钙血症危险因素。 结果 303例共切除甲状旁腺1 216枚。手术治愈率及成功率均为99%,284例手术当天骨痛及瘙痒缓解,19例1周左右缓解。术后第1天iPTH ［25.65(16.00,43.20)pg/mL］、血清磷［1.43(1.01,1.94)mmol/L］、血清钙［2.04(1.76,2.29)mmol/L］均较术前下降,差异有统计学意义(P<0.001)。术后出现低钙血症171例(56.44%),严重低钙血症106例(34.98%),皮下出血及血肿10例(3.3%),低血压休克2例(0.6%),皮下气肿1例(0.3%),急性脑梗死1例(0.3%),均经对症处理后恢复。单因素分析显示,年龄及术前血钙、碱性磷酸酶、iPTH差异有统计学意义(P<0.05);多因素分析显示,年龄、术前血钙、术前iPTH为术后严重低钙血症独立危险因素。 结论 PTX对尿毒症难治性SHPT是一种安全有效的治疗手段,术前血钙偏低、年龄较小、iPTH较高的患者术后容易发生严重低钙血症。

关键词: 继发性甲状旁腺功能亢进, 甲状旁腺切除术, 严重低钙血症

Abstract: Objective To investigate the perioperative safety and efficacy of parathyroidectomy(PTX)in the treatment of refractory secondary hyperparathyroidism(SHPT)and risk factors of postoperative severe hypocalcemia. Methods Atotal of 303 patients with refractory SHPT who underwent PTX in the 960th Hospital of the PLA Joint Logistics Support Force during Nov. 2010 and Dec. 2018 were involved. The preoperative and postoperative blood parathyroid hormone(iPTH), serum calcium, phosphorus and alkaline phosphatase were collected and statistically analyzed, and the postoperative complications and prognosis were observed. Univariate and multivariate analyses were performed for patients with severe hypocalcemia to determine the risk factors. Results A total of 1 216 parathyroid glands were resected in the 303 cases. The cure rate and success rate were both 99%. Symptoms of bone pain and itching were relieved in 284 cases on the day of operation, and in 19 cases 1 week after operation. On day-1 after operation, iPTH ［25.65(16.00, 43.20)pg/mL］, serum phosphorus ［1.43(1.01, 1.94)mmol/L］ and serum calcium ［2.04(1.76, 2.29)mmol/L］ were significantly lower than those before operation(P<0.001). Hypocalcemia occurred in 171 cases(56.44%)after operation, severe hypocalcemia in 106 cases(34.98%), subcutaneous hemorrhage and hematoma in 10 cases(3.3%), hypotension shock in 2 cases(0.6%), subcutaneous emphysema in 1 case(0.3%), and acute cerebral infarction in 1 case(0.3%). All patients recovered after symptomatic treatment. Univariate analysis showed that age, preoperative serum calcium, alkaline phosphatase and iPTH were significantly different(P<0.05). Multivariate analysis showed that age, preoperative serum calcium and iPTH were independent risk factors of severe hypocalcemia. Conclusion PTX is a safe and effective treatment for uremic refractory SHPT. Patients with low preoperative serum calcium, young age and high iPTH are prone to develop severe hypocalcemia after operation.

Key words: Secondary hyperparathyroidism, Parathyroidectomy, Severe hypocalcemia

中图分类号: 

  • R574
[1] 张建荣, 张凌. 慢性肾脏病继发性甲旁亢[M]. 北京: 人民军医出版社, 2010.
[2] Komaba H, Taniguchi M, Wada A, et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism [J]. Kidney Int, 2015, 88(2): 350-359.
[3] Goldsmith D, Kothawala P, Chalian A, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD [J]. Am J Kidney Dis, 2009, 53(6): 1002-1013.
[4] Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study [J]. Clin J Am Soc Nephrol, 2015, 10(1): 98-109.
[5] National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease [J]. Am J Kidney Dis, 2003, 42( Suppl 3): 1-201.
[6] Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder [J]. Ther Apher Dial, 2013, 17(3): 247-288.
[7] 田文, 贺青卿, 姜可伟, 等. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志, 2016, 36(5): 481-486.
[8] 周鹏, 贺青卿, 庄大勇, 等. 甲状旁腺全切加微量甲状旁腺自体移植术在肾性甲状旁腺功能亢进中的临床应用[J]. 中华内分泌外科杂志, 2018, 12(1): 34-38. ZHOU Peng, HE Qingqing, ZHUANG Dayong, et al. Application of total parathyroidectomy with autotransplantation in secondary hyperparathyroidism [J]. Chinese Journal of Endocrine Surgery, 2018, 12(1): 34-38.
[9] 周鹏, 庄大勇, 贺青卿, 等. 达芬奇机器人甲状旁腺全切加部分腺体自体移植术治疗肾性甲状旁腺功能亢进[J]. 中华普通外科杂志, 2018, 33(1): 49-52. ZHOU Peng, ZHUANG Dayong, HE Qingqing, et al. Use of da Vinci Si surgical system in total parathyroidectomy with autotransplantation for secondary renal hyperparathyroidism [J]. Chinese Journal of General Surgery, 2018, 33(1): 49-52.
[10] Sun X, Zhang X, Lu Y, et al. Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. Sci Rep, 2018, 8(1): 7743.
[11] Tsai WC, Peng YS, Chiu YL, et al. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism [J]. Int Urol Nephrol, 2015, 47(7): 1203-1207.
[12] Kidney Disease: Improving Global Outcomes(KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney International, 2009, 76(113): 1-130.
[13] Djukanovic L, Dimkovic N, Marinkovic J, et al. Association between hemodialysis patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism [J]. Nephron, 2016, 132(3): 168-174.
[14] Oliveira RB, Silva EN, Charpinel DM, et al. Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy [J]. J Bras Nefol, 2011, 33(4): 457-462.
[15] Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline Update [J]. Ann Intern Med, 2018, 168(6): 422-430.
[16] Wheeler DC, Winkelmayer AK, Abu-Alfa AK, et al. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney Int Suppl, 2017, 7(1): 1-59.
[17] 胡茂飞, 刘庆, 高新春, 等. 难治性SHPT治疗新理念:甲状旁腺肃清手术[J]. 中国现代普通外科进展, 2018, 21(8): 623-627.
[18] 胡茂飞, 林惠, 高新春, 等. TPTX与TPTX+AT治疗CKD患者SHPT预后的Meta分析[J]. 中国现代普通外科进展, 2018, 21(10): 783-790. HU Maofei, LIN Hui, GAO Xinchun, et al. Parathyroidectomy(TPTX versus TPTX+AT)for secondary hyperparathyroidism in chronic kidney disease: A Meta-Analysis [J]. Chinese Journal of Current Advances in General Surgery, 2018, 21(10): 783-790.
[19] Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism [J]. Clin J Am Soc Nephrol, 2018, 13(6): 952-961.
[20] Barczynski M, Golkowski F, Nawrot I. The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism [J]. Gland Surg, 2015, 4(1): 36-43.
[21] 刘新杰, 许楠, 蔡炜, 等. 术中甲状旁腺激素测定评判继发性甲状旁腺功能亢进手术成功的标准构想[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 65-70. LIU Xinjie, XU Nan, CAI Wei, et al. Conception of successive criterion of intraoperative parathyroid hormone assay during parathyroidectomy in secondary hyperparathyroidism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2): 65-70.
[22] 陈安举, 王田田, 薄少军, 等. 术中甲状旁腺激素测定在继发性甲状旁腺功能亢进手术中的临床应用价值[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(12): 1168-1172. CHEN Anju, WANG Tiantian, BO Shaojun, et al. Clinical value of intraoperative parathyroid hormone determination in secondary hyperparathyroidism operation [J]. Journal of Clinical Otolaryngology Head and Neck Surgery, 2019, 33(12): 1168-1172.
[23] 张小会, 胡成进, 王延群. 甲状旁腺激素及其他生化指标在继发性甲状旁腺功能亢进手术中的应用[J]. 国际检验医学杂志, 2019, 40(17): 2128-2131. ZHANG Xiaohui, HU Chengjin, WANG Yanqun. Application of parathyroid hormone and other biochemical indicators in the surgery of secondary hyperparathyroidism [J]. International Journal of Laboratory Medical, 2019, 40(17): 2128-2131.
[24] Cheng SP, Lee JJ, Liu TP, et al. Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism [J]. Surgery, 2014, 155(2): 320-328.
[25] Ishani A, Liu J, Wetmore JB, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis [J]. Clin J Am Soc Nephrol, 2015, 10(1): 90-97.
[26] Anwar F, Abraham J, Nakshabandi A, et al. Treatment of hypocalcemia in hungry bone syndrome: A case report [J]. Int J Surg Case Rep, 2018, 51: 335-339. doi: 10.1016/j.ijscr.2018.08.011.
[27] Ho LY, Wong PN, Sin HK, et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. BMC Nephrol, 2017, 18(1): 12.
[28] Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature [J]. Eur J Endocrinol, 2013, 168(3): 45-53.
[29] 艾向南, 金昌国, 欧阳才国, 等. 继发性甲状旁腺功能亢进患者甲状旁腺切除术后重度低钙血症相关因素分析[J]. 滨州医学院学报, 2015, 38(4): 257-259. AI Xiangnan, JIN Changguo, OUYANG Caiguo, et al. Analysis of factors associated with severe hypocalcemia after parathyroidectomy for secondary hyperparathyroidism patients [J]. Journal of Binzhou Medical University, 2015, 38(4): 257-259.
[1] 张伟,谭文浩,李贻斌. 基于深度强化学习的四足机器人运动控制发展现状与展望[J]. 山东大学学报 (医学版), 2020, 58(8): 61-66.
[2] 吴强,何泽鲲,刘琚,崔晓萌,孙双,石伟. 基于机器学习的脑胶质瘤多模态影像分析[J]. 山东大学学报 (医学版), 2020, 58(8): 81-87.
[3] 尹义龙,袭肖明,孟宪静. 阿尔兹海默病的智能诊断方法[J]. 山东大学学报 (医学版), 2020, 58(8): 14-21.
[4] 刘琚,吴强,于璐跃,林枫茗. 基于深度学习的脑肿瘤图像分割[J]. 山东大学学报 (医学版), 2020, 58(8): 42-49.
[5] 宋立,张艳,刘洋,王丹. 随访2年观察1例新发突变的营养不良型大疱性表皮松解症[J]. 山东大学学报 (医学版), 2020, 58(8): 120-122.
[6] 索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 58(7): 1-6.
[7] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 58(7): 7-14.
[8] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 58(7): 47-52.
[9] 冀永娟,项紫霓,匡桂芳. 青岛市两所三甲医院医务人员职业倦怠对生活质量影响的路径分析[J]. 山东大学学报 (医学版), 2020, 58(7): 102-107.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发